These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2022404)

  • 21. The use of the selective serotonin S2 receptor antagonist Ketanserin in the treatment of Raynaud's phenomenon.
    Dormandy JA; Berent A; Downes SJ
    Eur J Vasc Surg; 1988 Dec; 2(6):371-5. PubMed ID: 3075559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
    Smith CR; Rodeheffer RJ
    Am J Cardiol; 1985 Jan; 55(3):154B-157B. PubMed ID: 3881908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnosis and treatment of Raynaud's phenomenon: a practical approach.
    Pope JE
    Drugs; 2007; 67(4):517-25. PubMed ID: 17352512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Raynaud's phenomenon in children].
    Quartier P
    Arch Pediatr; 2004 Jan; 11(1):74-7. PubMed ID: 14700771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
    Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
    Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenon.
    Freedman RR; Mayes MD; Sabharwal SC
    Circulation; 1989 Oct; 80(4):859-62. PubMed ID: 2791249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effects and mechanism of action of ketanserin in patients with primary Raynaud's phenomenon.
    Brouwer RM; Wenting GJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):868-76. PubMed ID: 1694908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 7-oxo-DHEA and Raynaud's phenomenon.
    Ihler G; Chami-Stemmann H
    Med Hypotheses; 2003 Mar; 60(3):391-7. PubMed ID: 12581618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketanserin in the treatment of Raynaud's phenomenon associated with generalized scleroderma.
    Engelhart M
    Br J Dermatol; 1988 Dec; 119(6):751-4. PubMed ID: 3060193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketanserin and capillary flow in Raynaud's phenomenon.
    Tooke JE; Williams SA; Rawlinson DW; Black C
    Int J Microcirc Clin Exp; 1990 Aug; 9(3):249-55. PubMed ID: 2394546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis.
    Pope J; Fenlon D; Thompson A; Shea B; Furst D; Wells G; Silman A
    Cochrane Database Syst Rev; 2000; 1998(2):CD000954. PubMed ID: 10796396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of Raynaud's phenomenon.
    Seibold JR; Allegar NE
    Clin Dermatol; 1994; 12(2):317-21. PubMed ID: 8076271
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral vasodilators for primary Raynaud's phenomenon.
    Stewart M; Morling JR
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD006687. PubMed ID: 22786498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of ketanserin, a selective antagonist of the serotonin (5-HT2) receptors, in primary and secondary Raynaud's phenomenon.
    Meloni F; Transi MG; Sciacca V; De Felice C; Bagarone A; Sciacca A
    Angiology; 1987 Jul; 38(7):530-6. PubMed ID: 3619126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local and central orthostatic sympathetic reflexes in Raynaud's phenomenon.
    Engelhart M; Kristensen JK
    Scand J Clin Lab Invest; 1991 Apr; 51(2):191-6. PubMed ID: 2042023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Raynaud's syndrome, 2011].
    Takáts A; Garai I; Papp G; Hevér T; Csiki E; András C; Csiki Z
    Orv Hetil; 2012 Mar; 153(11):403-9. PubMed ID: 22390864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raynaud's phenomenon.
    Gayraud M
    Joint Bone Spine; 2007 Jan; 74(1):e1-8. PubMed ID: 17218139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifinger photoplethysmography and digital blood pressure measurement in patients with Raynaud's phenomenon of the hand.
    Tordoir JH; Haeck LB; Winterkamp H; Dekkers W
    J Vasc Surg; 1986 Mar; 3(3):456-61. PubMed ID: 3951030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational use of calcium-channel antagonists in Raynaud's phenomenon.
    Sturgill MG; Seibold JR
    Curr Opin Rheumatol; 1998 Nov; 10(6):584-8. PubMed ID: 9812220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raynaud's phenomenon.
    Wigley FM
    Curr Opin Rheumatol; 1993 Nov; 5(6):773-84. PubMed ID: 8117541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.